Voltar
Artigo Revisado por pares
BIBTEX RIS

PRETREATMENT URINARY HORMONE PATTERNS AND SURVIVAL IN PATIENTS WITH BREAST CANCER, PROSTATE CANCER, OR LUNG CANCER*

1969; Wiley; Volume: 164; Issue: 2 Linguagem: Inglês

10.1111/j.1749-6632.1969.tb14065.x

ISSN

1749-6632

Autores

Jessie Marmorston, Paul J. Geller, John M. Weiner,

Tópico(s)

Prostate Cancer Diagnosis and Treatment

Resumo

Annals of the New York Academy of SciencesVolume 164, Issue 2 p. 483-492 PRETREATMENT URINARY HORMONE PATTERNS AND SURVIVAL IN PATIENTS WITH BREAST CANCER, PROSTATE CANCER, OR LUNG CANCER* Jessie Marmorston, Jessie Marmorston University of Southern California School of Medicine Los Angeles, CalifSearch for more papers by this authorPaul J. Geller, Paul J. Geller University of Southern California School of Medicine Los Angeles, CalifSearch for more papers by this authorJohn M. Weiner, John M. Weiner University of Southern California School of Medicine Los Angeles, CalifSearch for more papers by this author Jessie Marmorston, Jessie Marmorston University of Southern California School of Medicine Los Angeles, CalifSearch for more papers by this authorPaul J. Geller, Paul J. Geller University of Southern California School of Medicine Los Angeles, CalifSearch for more papers by this authorJohn M. Weiner, John M. Weiner University of Southern California School of Medicine Los Angeles, CalifSearch for more papers by this author First published: October 1969 https://doi.org/10.1111/j.1749-6632.1969.tb14065.xCitations: 5 * Supported by the National Cancer Institute, USPHS Contract SA-43-PH-3714, and the Bella and Andre Meyer Foundation. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 ALTSCHUL, A. 1938. Gynecomastia in lung tumor. New York J. Med. 38: 637–640. Google Scholar 2 MOORE, R. A., M. L. MILLER & A. MCLELLAN. 1940. The urinary excretion of androgens by patients with benign hypertrophy of the prostate. J. Urol. 44: 727–737. CASWeb of Science®Google Scholar 3 DINGEMANSE, E. & E. LAQUEUR. 1940. The content of male and female hormone in the urine of patients with prostatic hypertrophy. J. Urol. 44: 530–540. 10.1016/S0022-5347(17)71299-2 CASWeb of Science®Google Scholar 4 HUGGINS, C. & C. V. HODGES. 1941. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1: 293–297. CASGoogle Scholar 5 FRAME, E. G. & H. J. JEWETT. 1944. The excretion of 17-ketosteroids in carcinoma of the prostate. J. Urol. 52: 330–333. CASWeb of Science®Google Scholar 6 HUGGINS, C. 1947. The etiology of benign prostatic hypertrophy. New York Acad. Med. Bull. 23: 696–704. CASPubMedWeb of Science®Google Scholar 7 MCCULLAGH, E. P., R. W. SCHNEIDER, W. BOWMAN & M. B. SMITH. 1948. Adrenal and testicular deficiency. J. Clin. Endocr. 8: 275–294. 10.1210/jcem-8-4-275 CASPubMedWeb of Science®Google Scholar 8 HUGGINS, C. & D. M. BERGENSTAL. 1951. Surgery of the adrenals. JAMA 147(2): 101–106. 10.1001/jama.1951.03670190001001 CASPubMedWeb of Science®Google Scholar 9 PEABODY, H. D. & A. M. OLSEN. 1951. Association of bronchogenic carcinoma and diabetes insipidus: report of cases. Proc. Mayo Clin. 26: 107–112. PubMedWeb of Science®Google Scholar 10 HUGGINS, C. 1952. Endocrine factors in cancer. J. Urol. 68: 875–884. 10.1016/S0022-5347(17)68297-1 CASPubMedWeb of Science®Google Scholar 11 HUGGINS, C. & D. M. BERGENSTAL. 1952. Inhibition of human mammary and prostatic cancers by adrenalectomy. Cancer Res. 12: 134–141. CASPubMedWeb of Science®Google Scholar 12 SOMMERS, S. C. 1955. Endocrine abnormalities in women with breast cancer. Lab. Invest. 4: 160–174. CASPubMedWeb of Science®Google Scholar 13 HUGGINS, C. 1956. Control of cancers of man by endocrinologic methods-A review. Cancer Res. 16(2): 825–830. CASPubMedWeb of Science®Google Scholar 14 SOMMERS, S. C. 1957. Endocrine changes with prostatic carcinoma. Cancer 10: 345–358. 10.1002/1097-0142(195703/04)10:2 3.0.CO;2-N CASPubMedWeb of Science®Google Scholar 15 SOMMERS, S. C. & W. A. MEISSNER. 1957. Endocrine abnormalities accompanying human endometrial cancer. Cancer 10: 516–521. 10.1002/1097-0142(195705/06)10:3 3.0.CO;2-6 CASPubMedWeb of Science®Google Scholar 16 KOVACH, R. D. & L. H. KYLE. 1958. Cushing's syndrome and bronchogenic carcinoma. Amer. J. Med. 24: 981–988. 10.1016/0002-9343(58)90351-6 CASPubMedWeb of Science®Google Scholar 17 BULBROOK, R. D., L. M. FRANKS & F. C. GREENWOOD. 1959. Hormone excretion in prostatic cancer: the early and late effects of endocrine treatment on urinary oestrogens, 17-ketosteroids and 17-ketogenic steroids. Acta Endocr. 31: 481–499. CASPubMedWeb of Science®Google Scholar 18 O'CONOR, V. J., JR., R. E. DESAUTELS, J. W. PRYOR, P. L. MUNSON & J. H. HARRISON 1959. Studies of hormonal changes in relation to cancer of the prostate: a progress report. J. Urol. 81: 468–473. 10.1016/S0022-5347(17)66045-2 CASPubMedWeb of Science®Google Scholar 19 HALL, P. F. 1959. In Gynaecomastia. Monographs of the Federal Council of the Brit. Med. Assn. in Australia. No. 2: 138–141. Web of Science®Google Scholar 20 VANDEWIELE, R. & S. LIEBERMAN. 1960. The metabolism of dehydroisoandrosterone.In Biological Activities of Steroids in Relation to Cancer. Academic Press, Inc. New York , N. Y. Google Scholar 21 WERK, E. E. & L. J. SHOLITON. 1960. Adrenocortical function in carcinoma of the lung. Cancer 13: 469–481. 10.1002/1097-0142(196005/06)13:3 3.0.CO;2-K CASPubMedWeb of Science®Google Scholar 22 ALLOIT, E. N. &' M. O. SKELTON. 1960. Increased adrenocortical activity associated with malignant disease. Lancet 2: 278–284. 10.1016/S0140-6736(60)91374-X PubMedWeb of Science®Google Scholar 23 DIAMOND, M. T. 1961. Carcinomatous neuropathy. Ann. Intern. Med. 54: 1259–1266. 10.7326/0003-4819-54-6-1259 CASPubMedWeb of Science®Google Scholar 24 WERK, E. E., L. J. SHOLITON, R. T. MARNELL & J. INCZE. 1961. Further studies of adrenocortical function in bronchogenic carcinoma. J. Lab. Clin. Med. 58: 972–973. Web of Science®Google Scholar 25 NAKANO, K. 1961. Endocrinological study of prostate cancer: effects of anti-androgenic treatments on urinary 17-ketosteroids and its fractionation. Jap. J. Urol. 52: 1047–1077. CASPubMedGoogle Scholar 26 MARKS, L. J., A. E. ANDERSON & H. LIBERMAN. 1961. Carcinoma of the lung associated with marked adrenocortical hyperplasia and adrenal hyper-responsiveness to ACTH in the absence of Cushing's syndrome. Ann. Intern. Med. 54: 1243–1248. 10.7326/0003-4819-54-6-1243 CASPubMedWeb of Science®Google Scholar 27 KARTEN, I. & H. BARTFELD. 1962. Bronchogenic carcinoma simulating early rheumatoid arthritis. JAMA 179: 162–163. 10.1001/jama.1962.03050020000013 CASPubMedWeb of Science®Google Scholar 28 WILLIAMS, M. J. & S. C. SOMMERS. 1962. Endocrine and certain other changes in men with carcinoma of the lung. Cancer 13: 559–601. PubMedWeb of Science®Google Scholar 29 BELSKY, J. L. & L. J. MARKS. 1962. Plasma 17-hydroxycorticosteroid responsiveness to ACTH in patients with bronchogenic carcinoma. Metabolism 11: 435–442. CASPubMedWeb of Science®Google Scholar 30 HYMES, A. C. & R. P. DOE. 1962. Adrenal function in cancer of the lung, with and without Cushing's syndrome. Amer. J. Med. 33: 398–407. 10.1016/0002-9343(62)90236-X CASPubMedWeb of Science®Google Scholar 31 HUGGINS, C. & N. C. YANG. 1962. Induction and extinction of mammary cancer. Science 137: 257–262. 10.1126/science.137.3526.257 CASPubMedWeb of Science®Google Scholar 32 BULBROOK, R. D., J. H. HAYWARD, C. C. SPICER & B. S. THOMAS. 1962. A comparison between the urinary steroid excretion of normal women and women with advanced breast cancer. Lancet 2: 1235–1237. 10.1016/S0140-6736(62)92811-8 CASPubMedWeb of Science®Google Scholar 33 BULBROOK, R. D., J. H. HAYWARD, C. C. SPICER & B. S. THOMAS. 1962. Abnormal excretion of urinary steroids by women with early breast cancer. Lancet 2: 1238–1240. 10.1016/S0140-6736(62)92812-X CASPubMedWeb of Science®Google Scholar 34 WILLIAMS, M. J. & S. C. SOMMERS. 1962. Endocrine and certain other changes in men with carcinoma of the lung. Cancer 15: 109–117. 10.1002/1097-0142(196201/02)15:1 3.0.CO;2-J CASPubMedWeb of Science®Google Scholar 35 PRUNTY, F. T. G., R. V. BROOKS, J. DUPRE, T. M. D. GIMLETTE, J. S. M. HUTCHINSON, R. R. MCSWINEY & I. H. MILLS. 1963. Adrenocortical hyperfunction and potassium metabolism in patients with “non-endocrine” tumors and Cushing's syndrome. J. Clin. Endocr. 23: 737–746. 10.1210/jcem-23-8-737 CASPubMedWeb of Science®Google Scholar 36 MARMORSTON, J., L. G. CROWLEY, S. M. MYERS, E. STERN & C. E. HOPKINS. 1965. Urinary excretion of neutral 17-ketosteroids and pregnanediol by patients with breast cancer and benign breast disease. Amer. J. Obstet. Gynec. 92: 447–459. 10.1016/S0002-9378(16)34834-7 CASPubMedWeb of Science®Google Scholar 37 MARMORSTON, J., L. G. CROWLEY, S. M. MYERS, E. STERN & C. E. HOPKINS. 1965. Urinary excretion of estrone, estradiol, and estriol by patients with breast cancer and benign breast disease. Amer. J. Obstet. Gynec. 92: 460–467. CASPubMedWeb of Science®Google Scholar 38 MARMORSTON, J., L. J. LOMBARDO, S. M. MYERS, H. W. GIERSON, E. STERN & C. E. HOPKINS. 1965. Urinary excretion of neutral 17-ketosteroids and pregnanediol by patients with prostatic cancer and benign prostatic hypertrophy. J. Urol. 93: 276–286. 10.1016/S0022-5347(17)63759-5 CASPubMedWeb of Science®Google Scholar 39 MARMORSTON, J., L. J. LOMBARDO, S. M. MYERS, H. W. GIERSON, E. STERN & C. E. HOPKINS. 1965. Urinary excretion of estrone, estradiol, and estriol by patients with prostatic cancer and benign prostatic hypertrophy. J. Urol. 93: 287–295. 10.1016/S0022-5347(17)63760-1 CASPubMedWeb of Science®Google Scholar 40 MARMORSTON, J., H. W. GIERSON, S. M. MYERS & E. STERN. 1965. Urinary excretion of neutral 17-ketosteroids and pregnanediol by patients with lung cancer and emphysema. Amer. Rev. Resp. Dis. 92: 404–416. CASPubMedWeb of Science®Google Scholar 41 MARMORSTON, J., H. W. GIERSON. S. M. MYERS & E. STERN. 1965. Urinary excretion of estrone, estradiol, and estriol by patients with lung cancer and emphysema. Amer. Rev. Resp. Dis. 92: 417–427. CASPubMedWeb of Science®Google Scholar 42 BECK, J. C., A. J. BLAIR, M. M. GRIFFITHS, M. W. ROSENFELD &E. E. MCGARRY. 1966. In search of hormonal factors as an aid in predicting the outcome of breast carcinoma. Canad. Cancer Conf. 6: 3–35. Google Scholar 43 BULBROOK, R. D. 1966. Hormonal factors in the etiology and treatment of breast cancer. Canad. Cancer Conf. 6: 36–49. Google Scholar 44 JULL, J. W. 1966. Hormonal mechanism in carcinogenesis. Canad. Cancer Conf. 6: 109–123. Google Scholar 45 CAMIEL, M. L., D. L. BENNINGHOFF & L. L. ALEXANDER. 1967. Gynecomastia associated with lung cancer. Dis. Chest 52: 445–450. 10.1378/chest.52.4.445 CASPubMedWeb of Science®Google Scholar 46 DAUGHTRY, D. C., J. G. CHESNEY, H. C. SPEAR, T. O. GENTSCH & P. B. LARSEN. 1967. Unexplained systemic manifestations of malignant lung tumors. Dis. Chest 52: 632–639. 10.1378/chest.52.5.632 CASPubMedWeb of Science®Google Scholar 47 FISHER, R. A. 1936. The use of multiple measurements in taxonomic problems. Ann. Eugen. 7: 179–188. 10.1111/j.1469-1809.1936.tb02137.x PubMedWeb of Science®Google Scholar 48 STERN, E., C. E. HOPKINS, J. M. WEINER & J. MARMORSTON. 1964. Hormone excretion patterns in breast and prostate cancer are abnormal. Science 145: 716–719. 10.1126/science.145.3633.716 CASPubMedWeb of Science®Google Scholar 49 MARMORSTON, J., J. M. WEINER, C. E. HOPKINS & E. STERN. 1966. Abnormalities in urinary hormone patterns in lung cancer and emphysema. Cancer 19: 985–995. 10.1002/1097-0142(196607)19:7 3.0.CO;2-J CASPubMedWeb of Science®Google Scholar 50 WEINER, J. M., J. MARMORSTON, E. STERN & C. E. HOPKINS. 1966. Urinary hormone metabolites in cancer and benign hyperplasia of the prostate: A multivariate statistical analysis. Ann. N. Y. Acad. Sci. 125: 974–983. 10.1111/j.1749-6632.1966.tb45449.x CASPubMedWeb of Science®Google Scholar 51 MARMORSTON, J. 1966. Urinary hormone metabolite levels in patients with cancer of the breast, prostate and lung. Ann. N. Y. Acad. Sci. 125: 959–973. 10.1111/j.1749-6632.1966.tb45448.x CASPubMedWeb of Science®Google Scholar 52 BRANTIGAN, O. C. 1967. Complacency in carcinoma of the lung. Dis. Chest 52: 173–185. 10.1378/chest.52.2.173 CASPubMedWeb of Science®Google Scholar 53 BOLOOKI, H. & S. MINKOWITZ. 1967. Evaluation of primary carcinoma of the lung and survival rate after curative resection in a large city hospital. Dis. Chest 52: 680–682. 10.1378/chest.52.5.680 CASPubMedWeb of Science®Google Scholar 54 BENNINGHOFF, D. L. & L. L. ALEXANDER. 1968. Treatment of lung carcinoma-radiation versus radiation combined with 5-fluorouracil. New York J. Med. 68: 532–534. Web of Science®Google Scholar 55 WATSON, W. L. & D. SCHOTTENFELD. 1968. Survival in cancer of the bronchus and lung, 1949-1962-Comparison of men and women patients. Dis. Chest 53: 65–72. 10.1378/chest.53.1.65 Web of Science®Google Scholar 56 WEINER, J. M. & O. J. DUNN. 1966. Elimination of variates in linear discrimination problems. Biometrics 22: 268–275. 10.2307/2528518 CASPubMedWeb of Science®Google Scholar 57 BULBROOK, R. D. & J. L. HAYWARD. 1967. Abnormal urinary steroid excretion and subsequent breast cancer. Lancet 1: 519–522. 10.1016/S0140-6736(67)92107-1 CASPubMedWeb of Science®Google Scholar 58 TOMKINS, G. M. 1968. Biological regulation by steroid hormones. Canad. Cancer Conf. 7: 163–174. Google Scholar 59 BUSH, I. E. 1963. Meth. Biochem. Anal. 11: 149–209. 10.1002/9780470110294.ch3 CASPubMedGoogle Scholar 60 ROBERTS, J. B., I. E. BUSH & N. B. GIBREE. 1968. Urinary steroid analysis: A comprehensive procedure. Anal. Biochem. In Press. 10.1016/0003-2697(68)90229-7 PubMedWeb of Science®Google Scholar Citing Literature Volume164, Issue2Second Conference on Psychophysiological Aspecs of CancerOctober 1969Pages 483-492 ReferencesRelatedInformation

Referência(s)